SD Biosensor, Inc. (KRX:137310)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,320.00
+360.00 (4.52%)
At close: May 22, 2026

SD Biosensor Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
718,784710,581694,574655,6772,932,0012,929,961
Other Revenue
-0-0--0--
718,784710,581694,574655,6772,932,0012,929,961
Revenue Growth (YoY)
2.17%2.31%5.93%-77.64%0.07%73.77%
Cost of Revenue
390,501389,132357,603533,2271,541,8911,336,785
Gross Profit
328,283321,449336,971122,4491,390,1101,593,176
Selling, General & Admin
224,972221,260194,593206,811169,176177,655
Research & Development
82,58778,05387,94664,20345,76219,086
Amortization of Goodwill & Intangibles
79,33484,02086,50676,2574,443506.34
Other Operating Expenses
6,8496,9383,2292,8103,5271,571
Operating Expenses
410,089404,302391,442370,534243,486205,443
Operating Income
-81,806-82,853-54,471-248,0851,146,6241,387,733
Interest Expense
-101,623-108,226-68,589-49,228-994.06-488.66
Interest & Investment Income
22,52024,22622,30423,48726,4866,702
Earnings From Equity Investments
-12,191-12,205----
Currency Exchange Gain (Loss)
58,32228,59030,876-22,71092,36265,296
Other Non Operating Income (Expenses)
-16,797-19,209-2,221-44,224-12,500-3,359
EBT Excluding Unusual Items
-131,576-169,677-72,101-340,7591,251,9791,455,883
Gain (Loss) on Sale of Investments
3,991-2,365-15,9103,059547.9512,282
Gain (Loss) on Sale of Assets
6,0227,6944,092-1,045-1,804-1,373
Asset Writedown
-753,790-753,790-135,262-99,869-8,634-2,283
Pretax Income
-875,353-918,139-219,181-438,6141,242,0881,464,509
Income Tax Expense
-403,094-404,750-121,04129,290333,300376,385
Earnings From Continuing Operations
-472,259-513,389-98,140-467,904908,7891,088,124
Minority Interest in Earnings
1,5321,283-271.22192.562,574346.26
Net Income
-470,727-512,106-98,411-467,712911,3621,088,471
Net Income to Common
-470,727-512,106-98,411-467,712911,3621,088,471
Net Income Growth
-----16.27%76.80%
Shares Outstanding (Basic)
12012012211110198
Shares Outstanding (Diluted)
12012012211110198
Shares Change (YoY)
-1.60%-2.11%10.27%9.44%3.87%4.28%
EPS (Basic)
-3935.13-4279.19-805.00-4218.958996.7611161.38
EPS (Diluted)
-3935.13-4279.19-805.00-4219.008996.7611161.00
EPS Growth
-----19.39%69.54%
Free Cash Flow
315,447300,43177,744-384,884587,0081,044,892
Free Cash Flow Per Share
2637.042510.42635.94-3471.825794.8110714.52
Gross Margin
45.67%45.24%48.52%18.68%47.41%54.37%
Operating Margin
-11.38%-11.66%-7.84%-37.84%39.11%47.36%
Profit Margin
-65.49%-72.07%-14.17%-71.33%31.08%37.15%
Free Cash Flow Margin
43.89%42.28%11.19%-58.70%20.02%35.66%
EBITDA
48,65751,41487,222-110,5431,187,4441,406,848
EBITDA Margin
6.77%7.23%12.56%-16.86%40.50%48.02%
D&A For EBITDA
130,464134,266141,694137,54140,82019,115
EBIT
-81,806-82,853-54,471-248,0851,146,6241,387,733
EBIT Margin
-11.38%-11.66%-7.84%-37.84%39.11%47.36%
Effective Tax Rate
----26.83%25.70%
Advertising Expenses
-6,9144,4765,98814,83010,329
Source: S&P Global Market Intelligence. Standard template. Financial Sources.